JP2882671B2 - Cosmetics - Google Patents
CosmeticsInfo
- Publication number
- JP2882671B2 JP2882671B2 JP26264790A JP26264790A JP2882671B2 JP 2882671 B2 JP2882671 B2 JP 2882671B2 JP 26264790 A JP26264790 A JP 26264790A JP 26264790 A JP26264790 A JP 26264790A JP 2882671 B2 JP2882671 B2 JP 2882671B2
- Authority
- JP
- Japan
- Prior art keywords
- hair
- urine
- effect
- cosmetic
- adjusted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002537 cosmetic Substances 0.000 title claims description 26
- 210000002700 urine Anatomy 0.000 claims description 53
- 239000008406 cosmetic ingredient Substances 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 16
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 241000124008 Mammalia Species 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 description 38
- 210000004209 hair Anatomy 0.000 description 22
- 238000012360 testing method Methods 0.000 description 19
- 210000003780 hair follicle Anatomy 0.000 description 16
- 238000004519 manufacturing process Methods 0.000 description 15
- 238000009472 formulation Methods 0.000 description 13
- 210000003491 skin Anatomy 0.000 description 13
- 230000003779 hair growth Effects 0.000 description 11
- 210000002510 keratinocyte Anatomy 0.000 description 10
- 239000006210 lotion Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 230000010261 cell growth Effects 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 239000006143 cell culture medium Substances 0.000 description 5
- 210000001626 skin fibroblast Anatomy 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000004663 cell proliferation Effects 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000003974 emollient agent Substances 0.000 description 3
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 230000009982 effect on human Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000007758 minimum essential medium Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000003658 preventing hair loss Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 1
- 210000003771 C cell Anatomy 0.000 description 1
- 238000011735 C3H mouse Methods 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000004266 Collagen Type IV Human genes 0.000 description 1
- 108010042086 Collagen Type IV Proteins 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000006173 Good's buffer Substances 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 241000282458 Ursus sp. Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000013096 assay test Methods 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 231100000640 hair analysis Toxicity 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 238000002847 impedance measurement Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- -1 oils and fats Chemical class 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は化粧料に関し、更に詳しくは、皮膚状態の改
善効果、頭髪の養毛効果、白髪改善効果のある化粧料に
関する。Description: BACKGROUND OF THE INVENTION The present invention relates to cosmetics, and more particularly, to cosmetics having an effect of improving skin conditions, a hair nourishing effect, and a white hair improving effect.
従来、皮膚状態の改善効果のある化粧料素剤としては
保湿剤、生薬抽出エキス、蛋白質、臓器抽出エキスなど
が知られている。2. Description of the Related Art Conventionally, moisturizers, extracts of crude drugs, proteins, and extracts of organs have been known as cosmetic ingredients having an effect of improving the skin condition.
頭髪の養毛効果のある化粧料素剤としては、生薬抽出
エキス、ホルモン類、ビタミン類などが知られている。Extracts of crude drugs, hormones, vitamins, and the like are known as cosmetic ingredients having a hair nourishing effect on hair.
また、白髪改善効果のある化粧料素剤としては生薬抽
出エキス、ホルモン類、ビタミン類などが知られてい
る。In addition, as a cosmetic ingredient having an effect of improving white hair, an extract of crude drug, hormones, vitamins and the like are known.
ところで、従来の皮膚状態の改善効果のある化粧料素
剤、養毛効果のある化粧料素剤、白髪改善効果のある化
粧料素剤は効果が劣ったり、ある程度の効果を示すもの
でも皮膚刺激を有したり皮膚状態を悪化させるなど問題
点があった。By the way, conventional cosmetic ingredients having an effect of improving skin condition, cosmetic ingredients having a hair nourishing effect, and cosmetic ingredients having an effect of improving white hair are inferior in effect or show a certain effect even if they exhibit a certain effect. And the skin condition is deteriorated.
本発明は、このような従来の問題点を解消するため、
皮膚の状態が悪化することなく、脱毛を防ぎ、あるいは
白髪を黒髪に改善する効果があって、副作用がほとんど
ない安全な化粧料素剤を配合してなる化粧料を提供する
ことを技術的課題とする。The present invention solves such a conventional problem,
It is a technical problem to provide a cosmetic composition comprising a safe cosmetic ingredient that has an effect of preventing hair loss or improving gray hair to black hair without deteriorating the skin condition and has almost no side effects. And
上記のような課題を解決するため、本発明の化粧料
は、ほ[哺]乳類から採取した尿に、脱アンモニア処理
と除菌処理とを施して得られる化粧料素剤を配合したも
のである。In order to solve the above-mentioned problems, the cosmetic of the present invention is obtained by mixing a urine collected from mammals with a cosmetic ingredient obtained by performing a deammonification treatment and a sterilization treatment. It is.
以下、本発明を更に詳しく説明する。 Hereinafter, the present invention will be described in more detail.
本発明の尿の採取に用いるほ[哺]乳類としては、ヒ
ト、サル、ウマ、ウシ、クマ、イヌ、ネコなどが挙げら
れる。The mammals used for collecting urine of the present invention include humans, monkeys, horses, cows, bears, dogs, cats, and the like.
本発明は、これらのほ[哺]乳類から採取した尿に脱
アンモニア処理と除菌処理とを施して得られる化粧料素
剤(以下、調整尿という)を配合してなる化粧料であ
る。The present invention is a cosmetic comprising a cosmetic ingredient (hereinafter referred to as adjusted urine) obtained by subjecting urine collected from these mammals to deammonification treatment and sterilization treatment. .
採取尿の脱アンモニア処理温度は室温がよい。処理温
度を50℃以上にすると採取尿に混入している有効成分が
分解してしまうので好ましくない。採取尿を液相から脱
アンモニアする場合、たとえばアンモニア捕獲カラム方
法を用いるとよい。The deammonia treatment temperature of the collected urine is preferably room temperature. When the treatment temperature is 50 ° C. or higher, it is not preferable because the active ingredient mixed in the collected urine is decomposed. When deammonifying the collected urine from the liquid phase, for example, an ammonia capture column method may be used.
除菌処理は、例えばろ過滅菌フィルターで採取尿をろ
過滅菌すればよい。The sterilization treatment may be performed, for example, by filtering and sterilizing the collected urine using a filtration sterilization filter.
上記のような方法によると、液状の調整尿を得ること
ができる。According to the method as described above, liquid adjusted urine can be obtained.
更に、採取尿を上述の方法で脱アンモニア処理、除菌
処理したのち凍結し、低温の固体状態から減圧乾燥する
いわゆる凍結乾燥法を用いると、採取尿中の有効成分を
ほとんど破壊することなく粉末状の調整尿を得ることが
出来て好ましい。Furthermore, the so-called freeze-drying method, in which the collected urine is deammonified and sterilized by the above-described method and then frozen, and then dried under reduced pressure from a low-temperature solid state, is used. It is preferable because it is possible to obtain a state-adjusted urine.
この粉末調整尿は水などの溶媒に再度溶解すると液状
の調整尿を得ることができる。When this powder adjusted urine is dissolved again in a solvent such as water, liquid adjusted urine can be obtained.
このようにして液状にあるいは粉末状で得られた調整
尿は、化粧料素剤として用いることができる。しかも、
このようにして得られた調整尿に、好ましくは炭酸水素
ナトリウム、グッド緩衝剤などのpH調整剤を併用すると
水素イオン濃度が安定化するので好ましい。この場合、
pHの調整は、塩酸あるいは水酸化ナトリウムなどで行う
が、調整尿の安定性から、pHは6〜8が好ましい。The adjusted urine thus obtained in liquid or powder form can be used as a cosmetic base. Moreover,
It is preferable to use a pH adjuster such as sodium bicarbonate or a good buffer in combination with the adjusted urine thus obtained, since the hydrogen ion concentration is stabilized. in this case,
The pH is adjusted with hydrochloric acid or sodium hydroxide, but the pH is preferably 6 to 8 in view of the stability of the adjusted urine.
液状又は粉末状で得たこのような調整尿は、必要に応
じてその濃度を調整し、その他の化粧料成分と混合して
本発明の化粧料にすることができる。Such a modified urine obtained in a liquid or powder form can be adjusted to a desired concentration and mixed with other cosmetic ingredients to form the cosmetic of the present invention.
上記のような本発明で用いる調整尿の使用量は、他の
化粧料成分を合算した化粧料全体の内、0.005〜90重量
%が可能であるが、粘性、皮膚に対する感触等を考慮す
ると、0.005〜40重量%が望ましい。The amount of the adjusted urine used in the present invention as described above can be 0.005 to 90% by weight of the total cosmetics including other cosmetic ingredients, but in consideration of viscosity, feel to the skin, and the like, 0.005 to 40% by weight is desirable.
使用量が0.005重量%未満の場合、顕著な細胞増殖効
果を確認することができず余り好ましくない。When the amount is less than 0.005% by weight, a remarkable cell growth effect cannot be confirmed, which is not preferable.
本発明の化粧料は、上記のような調整尿に本発明の目
的を損なわない範囲で、例えば次のような化粧料成分と
組み合わせて得ることができる。The cosmetic of the present invention can be obtained by combining the above-mentioned adjusted urine with the following cosmetic components within a range that does not impair the object of the present invention.
本発明の化粧料で、調整尿とともに配合する化粧料成
分としては、具体的には例えば、炭化水素類、ロウ類、
油脂類、エステル類、高級脂肪酸、高級アルコール、界
面活性剤などの基剤及び、香料、色素、防腐剤、抗酸化
剤、紫外線防御剤、アルコール類、薬効成分などの添加
成分を挙げることができる。In the cosmetic of the present invention, specific examples of the cosmetic ingredient to be mixed with the adjusted urine include, for example, hydrocarbons, waxes,
Bases such as oils and fats, esters, higher fatty acids, higher alcohols, and surfactants, and additional components such as fragrances, pigments, preservatives, antioxidants, ultraviolet protective agents, alcohols, and medicinal ingredients can be given. .
調整尿と例えば上記のような化粧料成分とを配合して
なる本発明の化粧料としては、具体的には例えば、エモ
リエントクリーム、ヘアローション、乳液、ヘアクリー
ム、軟膏などを挙げることができる。もっとも、本発明
の化粧料の範囲はこれらに限定されない。Specific examples of the cosmetic of the present invention, which is prepared by mixing the adjusted urine with the above-mentioned cosmetic ingredients, include, for example, emollient cream, hair lotion, milky lotion, hair cream, ointment and the like. However, the scope of the cosmetic of the present invention is not limited to these.
以下、本発明に用いる調整尿の製造例を示す。 Hereinafter, a production example of the adjusted urine used in the present invention will be described.
本発明の実施にあたって、以下に記すように先に調整
尿1〜5を製造し、その各一部を使用して効果実験を行
い、次いで、残余の各調整尿1〜5を使用して本発明の
化粧料を調製し、実施例の効果について確認した。In practicing the present invention, adjusted urine 1 to 5 are first manufactured as described below, effect experiments are performed using a part of each, and then the remaining adjusted urine 1 to 5 is prepared using the remaining adjusted urine 1 to 5. The cosmetics of the invention were prepared and the effects of the examples were confirmed.
<調整尿製造例1> 10人のヒトからそれぞれ50ccの尿を採取してそれを混
合し、アンモニア捕獲カラムにて脱アンモニア処理し
た。アンモニア捕獲カラム内の条件は室温とした。<Preparation Example 1 of Adjusted Urine> 50 cc of urine was collected from each of 10 humans, mixed with each other, and subjected to a deammonification treatment using an ammonia capture column. The conditions in the ammonia capture column were room temperature.
次いで、脱アンモニアした採取尿を室温条件下でろ過
滅菌し、化粧料素剤を得た。Next, the deammonia collected urine was sterilized by filtration under room temperature conditions to obtain a cosmetic base material.
<調整尿製造例2> 10匹のサルからそれぞれ10ccの尿を採取した他は調整
尿製造例1と同様にした。<Adjusted urine production example 2> The procedure was the same as that of Adjusted urine production example 1 except that 10 cc of urine was collected from each of 10 monkeys.
<調整尿製造例3> 10頭のウマからそれぞれ10ccの尿を採取した他は調整
尿製造例1と同様にした。<Adjusted urine production example 3> The same procedure was performed as in adjusted urine production example 1 except that 10 cc of urine was collected from each of 10 horses.
<調整尿製造例4> 10頭のウシからそれぞれ50ccの尿を採取した他は調整
尿製造例1と同様にした。<Adjusted urine production example 4> The procedure was the same as that of Adjusted urine production example 1 except that 50 cc of urine was collected from each of 10 cows.
<調整尿製造例5> 10匹のイヌからそれぞれ10ccの尿を採取した他は調整
尿製造例1と同様にした。<Adjusted urine production example 5> The procedure was the same as that of Adjusted urine production example 1 except that 10 cc of urine was collected from each of 10 dogs.
<細胞増殖効果検定試験> ヒト皮膚繊維芽細胞、ヒト皮膚表皮ケラチノサイト、
ヒト毛包ケラチノサイトそれぞれについて細胞増殖効果
検定試験を行った。<Cell proliferation effect assay> Human skin fibroblasts, human skin keratinocytes,
A cell proliferation effect assay test was performed on each of the human hair follicle keratinocytes.
A 繊維芽細胞を用いた細胞増殖促進試験 培養対象 ヒト皮膚繊維芽細胞 基質 60mmφの市販培養皿 細胞培養培地 最小必須培地(MEM)にウシ胎児血清(F
BS)を1体積%混合した混合培地 気相条件 5体積%の炭酸ガスを混ぜ合わせた空気 温度 37℃ 上記の条件で、それぞれ10万個づつの繊維芽細胞を6
個の培養皿に計60万個投入した。次いで、その6個の培
養皿の内4個の培養皿にそれぞれ調整尿製造例1〜3の
化粧料素剤を表1に示す量で添加した。また、化粧料素
剤を添加しない培養皿1個をコントロールとし、残りも
う1個の培養皿には従来の養毛化粧料素剤ビタミンEを
比較例として添加した。A Cell growth promotion test using fibroblasts Culture target Human skin fibroblasts Substrate 60 mmφ commercial culture dish Cell culture medium Minimum essential medium (MEM) is fetal bovine serum (F
A mixed medium containing 1% by volume of BS) Gas phase conditions Air mixed with 5% by volume of carbon dioxide Temperature 37 ° C Under the above conditions, 100,000 fibroblasts of 6 million each were grown.
A total of 600,000 pieces were put into each culture dish. Next, the cosmetic ingredients of Adjusted Urine Production Examples 1 to 3 were added to four of the six culture dishes in amounts shown in Table 1, respectively. In addition, one culture dish to which no cosmetic base was added was used as a control, and the other culture dish was added with a conventional hair growth cosmetic base, vitamin E, as a comparative example.
なお、化粧料素剤を添加後、添加した培養皿の塩分濃
度が生理的塩類濃度から外れないよう、添加前にそれぞ
れの化粧料素剤には計算量の塩類をあらかじめ加えた。After the addition of the cosmetic ingredients, a calculated amount of salts was previously added to each cosmetic ingredient so that the salt concentration of the added culture dish did not deviate from the physiological salt concentration.
96時間培養後、各培養皿中の培養細胞をトリプシンで
剥離し、細胞数を血球計算盤で計測した。After culturing for 96 hours, the cultured cells in each culture dish were detached with trypsin, and the number of cells was counted with a hemocytometer.
コントロールで得られた細胞数を100%として結果を
表1に示す。The results are shown in Table 1 assuming that the number of cells obtained in the control was 100%.
B 表皮ケラチノサイトを用いた細胞増殖促進試験 培養対象 ヒト皮膚表皮ケラチノサイト 基質 60mmφの市販培養皿にIV型コラーゲンを塗布 細胞培養培地 最小必須培地(MEM)にウシ胎児血清(F
BS)を1体積%混合し、更にカルシウム濃度を0.3mMと
した混合培地 上記の培養対象、基質、細胞培養培地の他は、繊維芽
細胞培養方法に準じた。 B Cell proliferation promotion test using epidermal keratinocytes Culture target Human skin epidermal keratinocytes Substrate Type IV collagen is applied to a commercial culture dish of 60 mmφ Cell culture medium The minimum essential medium (MEM) is fetal bovine serum (F)
BS) was mixed at 1% by volume and the calcium concentration was further adjusted to 0.3 mM. The medium other than the above-mentioned culture target, substrate and cell culture medium was the same as the fibroblast culture method.
使用した化粧料素剤の種類と量、更に、測定結果を表
2に示す。Table 2 shows the types and amounts of the cosmetic ingredients used, and the measurement results.
C 毛包ケラチノサイトを用いた細胞増殖促進試験 培養対象 ヒト毛包ケラチノサイト 培養対象の他は、ヒト皮膚ケラチノサイト培養方法に
準じた。 C Cell proliferation promotion test using hair follicle keratinocytes Culture target Human hair follicle keratinocytes Other than the culture target, the human skin keratinocyte culture method was followed.
使用した化粧料素剤の種類と量、更に、測定結果を表
3に示す。Table 3 shows the types and amounts of the cosmetic ingredients used and the measurement results.
表1〜3より、各調整尿製造例の化粧料素剤を細胞培
養系に対して添加すると顕著な細胞増殖促進効果がある
ことが分かり、本発明に用いる化粧料素剤が皮膚あるい
は毛包を構成する細胞に賦活作用を有することが分かっ
た。 From Tables 1 to 3, it can be seen that when the cosmetic ingredients of each of the adjusted urine production examples were added to the cell culture system, there was a remarkable cell growth promoting effect, and the cosmetic ingredients used in the present invention were skin or hair follicles. Was found to have an activating effect on the cells constituting
<毛包黒化試験> マウスの毛包を用いて黒化試験を行った。<Black hair follicle test> A black hair test was performed using mouse hair follicles.
試験対象 Ayマウスの毛包 細胞培養培地 最小必須培地(MEM)にウシ胎児血清(F
BS)を15体積%混合した混合培地 上記試験対象毛包およそ100本と細胞培養培地5ccとを
組み合わせて4本の試験管1つ1つに入れ、その内の2
本の試験管に調整尿製造例1の化粧料素剤、1本の試験
管に比較例として従来の養毛化粧料素剤ビタミンEを、
それぞれ表4に示す量で添加した。残り1本の試験管は
コントロールとした。Test subjects Hair follicles from Ay mice Cell culture medium Fetal bovine serum (F)
About 100 hair follicles to be tested and 5 cc of cell culture medium are combined into each of four test tubes, and 2 of them are mixed.
In one test tube, the cosmetic base material of Preparation Urine Production Example 1 was used, and in one test tube, a conventional hair growth cosmetic base material Vitamin E was used as a comparative example.
Each was added in the amounts shown in Table 4. The remaining one test tube was used as a control.
気相条件と温度と、更に、塩分の調整は養毛効果試験
の場合に準じた。Adjustment of the gas-phase conditions and temperature, and further, the salt content were the same as in the case of the hair growth effect test.
2日間回転培養を行った。 Rotary culture was performed for 2 days.
結果を表4に示す。 Table 4 shows the results.
上記の結果から、各調整尿製造例には毛包のメラノサ
イトに作用して毛包を黒化させる作用があることが確認
された。 From the above results, it was confirmed that each adjusted urine production example had an effect of acting on melanocytes of hair follicles to blacken hair follicles.
<育毛効果試験> マウス10匹の背部を用いて育毛効果試験を行った。<Hair-growth effect test> A hair-growth effect test was performed using the back of 10 mice.
すなわち、9週令のC3Hマウス70匹(各検体塗布群で1
0匹づつ)の背部をそれぞれ2.0×2.0cmの広さに除毛
し、翌日、各除毛部位に各調整尿製造例1,2,4,5、ま
た、コントロールとしてエタノール、水、更に、従来の
養毛効果化粧料素剤であるビタミンEを比較例として、
それぞれ塗布した。That is, 70 C3H mice 9 weeks old (1 for each sample application group)
The hair of each of the 0) was shaved to a size of 2.0 × 2.0 cm, and the following day, each of the adjusted urine production examples 1,2,4,5, and ethanol, water as a control, and As a comparative example, vitamin E, which is a conventional hair growth effect cosmetic ingredient,
Each was applied.
5日目,14日目にその部位の毛成長の密度を色差計を
用いて測定し、その結果を黒色増加度としてとらえた。On the 5th and 14th days, the density of hair growth at the site was measured using a color difference meter, and the result was taken as the degree of black increase.
結果を表5に示す。 Table 5 shows the results.
この結果より調整尿にはマウス毛成長促進作用がある
ことが分かった。 These results indicate that the adjusted urine has a mouse hair growth promoting effect.
以下、実施例と対照品にて本発明を説明するが、本発
明はこれら実施例に制限されるものではない。Hereinafter, the present invention will be described with reference to Examples and Comparative Examples, but the present invention is not limited to these Examples.
尚、配合量は重量部である。 In addition, the compounding amount is a weight part.
<実施例1> 表6に示す処方でエモリエントクリームを調製した。<Example 1> An emollient cream was prepared according to the formulation shown in Table 6.
上記処方物Aを混合加熱して70℃とする。これに上記
処方物Bを同様に混合加熱して、70℃としたものを加
え、ホモミキサーで均一に乳化し、冷却して40℃になっ
たところで上記Cを加えて再び冷却し、本発明の1実施
態様であるエモリエントクリームを得る。 The above formulation A is mixed and heated to 70 ° C. The above formulation B was similarly mixed and heated to a temperature of 70 ° C., and was uniformly emulsified with a homomixer. When cooled to 40 ° C., the above C was added and cooled again. An emollient cream which is one embodiment of the invention is obtained.
<実施例2> 表7に示す処方で化粧水を調製した。<Example 2> A lotion was prepared according to the formulation shown in Table 7.
上記処方物A及びBを加温溶解し、BにAを加え、可
溶化し、本発明の1実施態様である化粧水を得る。 The above formulations A and B are heated and dissolved, A is added to B and solubilized to obtain a lotion according to one embodiment of the present invention.
<製品効果試験> 《保湿効果試験》 冬期、乾性肌や荒れ肌の男女40名のパネラーの右手の
甲全面に上記実施例1を塗布し、実施例1の調整尿のか
わりに同量の精製水を用いた他は実施例1と同様にした
対照品を左手の甲に塗布した。<Product effect test><< Moisturizing effect test >> In winter, the above Example 1 was applied to the entire back of the right hand of a panel of 40 men and women with dry or rough skin, and the same amount of purified water was used instead of the adjusted urine of Example 1. A control product similar to that of Example 1 was applied to the back of the left hand except that it was used.
4時間後、左右の皮膚の水分状態をインピーダンス測
定によって評価した。After 4 hours, the water status of the left and right skin was evaluated by impedance measurement.
その結果、同一個人内において、右の甲のインピーダ
ンス値は、スチューデントのペアードtテストにより、
左の甲に比して5%以下の有為差をもって高い値を示
し、保湿効果を有することが分かった。As a result, within the same individual, the impedance value of the right instep was determined by the student's paired t test.
It showed a high value with a significant difference of 5% or less as compared with the left upper, indicating that it had a moisturizing effect.
《肌状態改善効果試験》 保湿効果試験を行った同じパネラーに、実施例2の化
粧水を、毎日3回、30日間に渡って右手の甲に塗布し
た。また、実施例2の調整尿のかわりに精製水を用いた
他は実施例2と同様にした対照品を左手の甲に塗布し
た。<< Skin condition improvement effect test >> To the same panelists who performed the moisturizing effect test, the lotion of Example 2 was applied to the back of the right hand three times daily for 30 days. A control product similar to that of Example 2 except that purified water was used instead of the adjusted urine of Example 2 was applied to the back of the left hand.
30日後、官能評価項目として肌のかさつきの改善度を
表8の評点により評価し、40名の平均値を求めた。Thirty days later, as a sensory evaluation item, the degree of improvement of the bulkiness of the skin was evaluated based on the scores in Table 8, and the average value of 40 persons was obtained.
結果を表9に示す。 Table 9 shows the results.
表9より明かなように、本発明品には肌のかさつき改
善効果が認められた。 As is clear from Table 9, the product of the present invention was found to have an effect of improving the bulkiness of the skin.
<実施例3> 表10に示す処方でヘアローションを調製した。Example 3 A hair lotion was prepared according to the formulation shown in Table 10.
上記処方物を加温溶解し、可溶化し、本発明の1実施
態様であるヘアローションを得る。 The above formulation is dissolved by heating and solubilized to obtain a hair lotion which is one embodiment of the present invention.
《育毛効果試験》 薄毛症を訴える13名のパネラーに、実施例3に示すヘ
アローションを使用させて育毛効果試験を実施した。す
なわち、連続5箇月間通常のローションの使用法と同
様、一日2回、頭部にまんべんなく塗布してもらった。<< Hair-growth effect test >> A hair-growth effect test was carried out by using the hair lotion shown in Example 3 to 13 panelists complaining of hair thinning. That is, in the same manner as a normal lotion usage for five consecutive months, the head was evenly applied twice a day.
評価は使用開始後3箇月と5箇月後に行った。結果を
表11に示す。The evaluation was performed three and five months after the start of use. Table 11 shows the results.
このテスト終了時に白髪の減少を申告したものが4名
存在した。また、頭皮の状態も改善され、ふけの発生の
減少を申告したものが7名存在した。 At the end of this test, there were four people who reported reduction in gray hair. In addition, the condition of the scalp was also improved, and there were 7 people who reported reduction in the occurrence of dandruff.
<実施例4> 表12に示す処方で乳液を調製した。Example 4 An emulsion was prepared according to the formulation shown in Table 12.
上記処方物Aを混合加熱して70℃とする。これに上記
処方物Bを同様に混合加熱して、70℃としたものを加
え、ホモミキサーで均一に乳化し、冷却して40℃になっ
たところで上記Cを加えて再び冷却し、本発明の1実施
態様である乳液を得る。 The above formulation A is mixed and heated to 70 ° C. The above formulation B was similarly mixed and heated to a temperature of 70 ° C., and was uniformly emulsified with a homomixer. When cooled to 40 ° C., the above C was added and cooled again. An emulsion is obtained which is one embodiment of the invention.
<実施例5> 表13に示す処方でヘアクリームを調製した。Example 5 A hair cream was prepared according to the formulation shown in Table 13.
上記処方物Aを混合加熱して80℃とする。これに上記
処方物Bを同様に混合加熱して、80℃としたものを加
え、ホモミキサーで均一に乳化し、冷却して40℃になっ
たところで上記Cを加えて再び冷却し、本発明の1実施
態様であるヘアクリームを得る。 The above formulation A is mixed and heated to 80 ° C. In the same manner, the above formulation B was mixed and heated to 80 ° C., and the mixture was uniformly emulsified with a homomixer. When cooled to 40 ° C., the above C was added and cooled again. To obtain a hair cream which is one embodiment of the present invention.
調整尿には次の効果が認められた。すなわち、ヒト皮
膚繊維芽細胞、ヒト皮膚表皮ケラチノサイト、ヒト毛包
ケラチノサイトで細胞増殖効果、毛包黒化作用及び養毛
効果があった。このことから、調整尿を化粧料素剤に用
いると、それを配合してある化粧料にはヒト皮膚繊維芽
細胞、ヒト皮膚表皮ケラチノサイト、ヒト毛包ケラチノ
サイトで細胞増殖効果、毛包黒化作用及び養毛効果が認
められることも十分に分かった。The following effects were observed in the adjusted urine. That is, human skin fibroblasts, human skin epidermal keratinocytes, and human hair follicle keratinocytes had a cell growth effect, a hair follicle blackening effect, and a hair nourishing effect. From this, when the adjusted urine is used as a cosmetic ingredient, the cosmetics containing it have a cell growth effect on human skin fibroblasts, human skin keratinocytes, and human hair follicle keratinocytes, and a hair follicle blackening effect. It was also found that the hair growth effect was recognized.
このことから、本発明の化粧料は、ヒト皮膚繊維芽細
胞、ヒト皮膚表皮ケラチノサイト、ヒト毛包ケラチノサ
イトて細胞増殖効果、毛包黒化作用及び養毛効果があ
る。Therefore, the cosmetic of the present invention has a cell growth effect, a hair follicle blackening effect and a hair nourishing effect on human skin fibroblasts, human skin keratinocytes, and human hair follicle keratinocytes.
またこの他にも、本発明の化粧料は、皮膚のかさつき
が改善され、脱毛を防ぎ、あるいは白髪を黒髪に戻す効
果があって、副作用がほとんどなく安全である。In addition, the cosmetic of the present invention has an effect of improving the bulkiness of the skin, preventing hair loss or returning gray hair to black hair, and is safe with almost no side effects.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 横山 由紀子 神奈川県横浜市神奈川区高島台27番地1 ポーラ化成工業株式会社横浜研究所内 (72)発明者 鈴木 正巳 神奈川県横浜市神奈川区高島台27番地1 ポーラ化成工業株式会社横浜研究所内 (58)調査した分野(Int.Cl.6,DB名) A61K 7/00,7/06 ──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Yukiko Yokoyama 27-1 Takashimadai, Kanagawa-ku, Kanagawa-ku, Yokohama, Japan Inside the Polar Chemical Industry Co., Ltd. Yokohama Research Laboratory (72) Inventor Masami Suzuki 27-27 Takashimadai, Kanagawa-ku, Yokohama, Kanagawa 1 Pola Kasei Kogyo Co., Ltd. Yokohama Research Laboratory (58) Field surveyed (Int. Cl. 6 , DB name) A61K 7/00, 7/06
Claims (2)
ニア処理と除菌処理とを施して得られる化粧料素剤を配
合してなる化粧料。(1) A cosmetic composition comprising a urine collected from mammals and a cosmetic ingredient obtained by subjecting the urine to deammonification treatment and sterilization treatment.
る請求項1に記載の化粧料。2. The cosmetic according to claim 1, wherein the cosmetic base is in a powder form.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26264790A JP2882671B2 (en) | 1990-09-28 | 1990-09-28 | Cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26264790A JP2882671B2 (en) | 1990-09-28 | 1990-09-28 | Cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH04159205A JPH04159205A (en) | 1992-06-02 |
| JP2882671B2 true JP2882671B2 (en) | 1999-04-12 |
Family
ID=17378686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP26264790A Expired - Fee Related JP2882671B2 (en) | 1990-09-28 | 1990-09-28 | Cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2882671B2 (en) |
-
1990
- 1990-09-28 JP JP26264790A patent/JP2882671B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04159205A (en) | 1992-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3513873B2 (en) | External preparation for skin | |
| JP2000191498A (en) | Collagen production facilitative agent and preparation for external use for skin | |
| JPH0469123B2 (en) | ||
| US6193975B1 (en) | Use of potentilla erecta extract in the cosmetic and pharmaceutical field | |
| JP2912489B2 (en) | Skin cosmetics | |
| JP2988803B2 (en) | Skin aging prevention cosmetic composition | |
| JPH05124930A (en) | Cosmetics | |
| JPH069422A (en) | Promoter for biosynthesis of hyaluronic acid | |
| JPH0551314A (en) | Skin cosmetics | |
| RU2119790C1 (en) | Agent for biological skin rejuvenation | |
| JPH03112912A (en) | Cosmetic composition | |
| JP2008088075A (en) | Profilaggrin/filaggrin production promoter, epidermal keratinocyte proliferation promoter, skin care preparation for normalizing epidermis/horny cell layer, profilaggrin/filaggrin production-promoting method and epidermal keratinocyte proliferation-promoting method | |
| JP2882671B2 (en) | Cosmetics | |
| KR101322850B1 (en) | The cosmetic composition for pore-minimizing and inhibition of Sebum Secretion containing the extract of leaves of Mentha arvensis var. piperascens, wheat bud, and Platycodon grandiflorum | |
| JP2003146886A (en) | Filaggrin synthesis accelerator, improver for moisture- retaining function of horny layer, horny layer softener and enhancer of isolated amino acid in horny layer | |
| JPH0820522A (en) | Keratinizing anzyme activity promoter and cosmetic containing the same | |
| JP2026506283A (en) | Compositions containing an extract of Epilobium fleischeri for treating signs of aging | |
| JP3277033B2 (en) | Cosmetics | |
| JP3083105B2 (en) | Cosmetics | |
| JP2001139436A (en) | Hair tonic and grower | |
| JP2000128741A (en) | Hair papilla activator | |
| EP1075835A1 (en) | Use of aminodiol derivatives in skin cosmeics | |
| JP2003519663A (en) | Use of Dictyotal extract in the manufacture of a topical pharmaceutical composition | |
| JPH0676296B2 (en) | Nourishing skin cosmetics | |
| US20020192177A1 (en) | Hair tonic composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |